|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | SJGT14082900000151显示文摘 | Jean-Marc Dumonceau Angelo Andriulli B. Elmunzer Alberto Mariani Tobias Meister Jacques Deviere Tomasz Marek Todd Baron Cesare Hassan Pier Testoni Christine Kapral | 2014 | Endoscopy2014，，： | 3 |
| 2 | Risk Stratification in Upper Gastrointestinal Bleeding显示文摘 | Badih Joseph Elmunzer John M. Inadomi Grace H. Elta | 2007 | Journal of Clinical Gastroenterology2007，，6： | 3 |
| 3 | Prophylactic 5-Fr pancreatic duct stents are superior to 3-Fr stents: a randomized controlled trial显示文摘 | E. Zolotarevsky S. Fehmi M. Anderson P. Schoenfeld B. Elmunzer R. Kwon C. Piraka E.-J. Wamsteker J. Scheiman S. Korsnes D. Normolle H. Kim G. Elta | 2011 | Endoscopy2011，，04： | 2 |
| 4 | Outcomes of submucosal(T1b) esophageal adenocarcinomas removed by endoscopic mucosal resection显示文摘AIM To investigate the outcomes and recurrences of p T1 b esophageal adenocarcinoma(EAC) following endoscopic mucosal resection(EMR) and associated treatments.METHODS Patients undergoing EMR with pathologically confirmed T1 b EAC at two academic referral centers were retrospectively identified.Patients were divided into 4 groups based on treatment following EMR:Endoscopic therapy alone(group A),endoscopic therapy with either chemotherapy,radiation or both(group B),surgicalresection(group C) or no further treatment/lost to follow-up(<12 mo)(group D).Pathology specimens were reviewed by a central pathologist.Follow-up data was obtained from the academic centers,primary care physicians and/or referring physicians.Univariate analysis was performed to identify factors predicting recurrence of EAC.RESULTS Fifty-three patients with T1 b EAC underwent EMR,of which 32(60%) had adequate follow-up ≥ 12 mo(median 34 mo,range 12-103).There were 16 patients in group A,9 in group B,7 in group C and 21 in group D.Median follow-up in groups A to C was 34 mo(range 12-103).Recurrent EAC developed overall in 9 patients(28%) including 6(38%) in group A(median:21 mo,range:6-73),1(11%) in group B(median:30 mo,range:30-30) and 2(29%) in group C(median 21 mo,range:7-35.Six of 9 recurrences were local;of the 6 recurrences,5 were treated with endoscopy alone.No predictors of recurrence of EAC were identified.CONCLUSION Endoscopic therapy of T1 b EAC may be a reasonable strategy for a subset of patients including those either refusing or medically unfit for esophagectomy. | Darren D Ballard Neel Choksi Jingmei Lin Eun-Young Choi B Joseph Elmunzer Henry Appelman Douglas K Rex Hala Fatima William Kessler John M DeWitt | 2016 | World Journal of Gastrointestinal Endoscopy2016，8，20： | 2 |
| 5 | Is MRCP equivalent to ERCP for diagnosing biliary obstruction in orthotopic liver transplant recipients? A meta-analysis显示文摘 | Jennifer E. Jorgensen Akbar K. Waljee Michael L. Volk Christopher J. Sonnenday Grace H. Elta Mahmoud M. Al-Hawary Amit G. Singal Jason R. Taylor B. Joseph Elmunzer | 2011 | Gastrointestinal Endoscopy2011，，5： | 2 |
| 6 | Risk stratification in upper gastrointestinal bleeding显示文摘 | Elmunzer BJ Inadomi JM Elta GH | 2007 | J Clin Gastroenterol2007，41，6： | 1 |
| 7 | Prophylaxis of post-ERCP pancreatitis:European Society of Gastrointestinal Endoscopy(ESGE)Guideline - updated June 2014显示文摘 | Dumonceau JM Andriulli A Elmunzer BJ | 2014 | Endoscopy2014，46，9： | 1 |
| 8 | A random- ized trial of reetal indomethaein to prevent post-ERCP panereatitis显示文摘 | Elmunzer BJ Scheiman JM Lehman GA | 2012 | N Engl J Med2012，366，15： | 1 |
| 9 | Risk stratification in upper gas-troin testinal bleeding显示文摘 | Elmunzer BJ Inadomi JM Elta GH | | 0，，06： | 1 |
| 10 | In vivo mo- lecular imaging of Barrett' s esophagus with confocal la- ser endomicroscopy显示文摘 | Sturm M B Piraka C Elmunzer B J | 2013 | Gastroenterology2013，145，1： | 1 |
| 11 | A meta-analysis of NSAIDs in the prevention of post ERCP pancreatits显示文摘 | Elmunzer BJ Waljee AK Elta GH | 2008 | Gut2008，57，： | 1 |
| 12 | A randomized trial of rectal indomethacin to prevent post - ERCP pancreatitis显示文摘 | Elmunzer B J Scheiman J M Lehman G A | 2012 | N En- gl J Med2012，366，15： | 1 |
| 13 | Risk stratification in upper gastroin testinal bleeding显示文摘 | Elmunzer BJ Inadomi JM Eha GH | 2007 | J Clin Gastroenterol2007，41，6： | 1 |
| 14 | Risk stratification in upper gastroin testinal bleeding显示文摘 | Elmunzer BJ Inadomi JM Elta GH | 2007 | J Clin Gastroenterol2007，41，6： | 1 |
| 15 | In Vivo Molecular Imaging of Barrett’s Esophagus With Confocal Laser Endomicroscopy显示文摘 | Matthew B. Sturm Cyrus Piraka B. Joseph Elmunzer Richard S. Kwon Bishnu P. Joshi Henry D. Appelman D. Kim Turgeon Thomas D. Wang | 2013 | Gastroenterology2013，，1： | 1 |
| 16 | Incidence, severity, and mortality of post-ERCP pancreatitis: a systematic review by using randomized, controlled trials显示文摘 | Bharati Kochar Venkata S. Akshintala Elham Afghani B. Joseph Elmunzer Katherine J. Kim Anne Marie Lennon Mouen A. Khashab Anthony N. Kalloo Vikesh K. Singh | 2014 | Gastrointestinal Endoscopy2014，，： | 1 |
| 17 | A survey of expert follow-up practices after successful endoscopic eradication therapy for Barrett’s esophagus with high-grade dysplasia and intramucosal adenocarcinoma显示文摘 | Aarti O. Bedi Richard S. Kwon Joel H. Rubenstein Cyrus R. Piraka Grace H. Elta James M. Scheiman B. Joseph Elmunzer | 2013 | Gastrointestinal Endoscopy2013，，5： | 1 |
| 18 | Risk stratification in upper gastrointestinal bleeding 显示文摘 | Elmunzer B J Inadomi JM Elta GH | 2007 | J Clin Gastroenterol2007，41，6： | 1 |
| 19 | A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis 显示文摘 | Elmunzer B J Scheiman JM Lehman GA | 2012 | N Engl J Med2012，366，15： | 1 |
| 20 | A ran- domized trial of rectal indomethacin to prevent post - ERCP pancreatitis显示文摘 | ELMUNZER B J SCHEIMAN JM LEHMAN GA | 2012 | N Engl J Med2012，366，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员